Active Ingredient(s): Indacaterol Maleate
FDA Approved: * July 1, 2011
Pharm Company: * NOVARTIS PHARMS
Category: Lungs (Pulmonary)

Indacaterol is an ultra-long-acting beta-adrenoceptor agonist[5] developed by Novartis. It needs to be taken only once a day,[6] unlike the related drugs formoterol and salmeterol. It is licensed only for the treatment of chronic obstructive pulmonary disease (COPD) (long-term data in patients with asthma are thus far lacking). It is delivered as an aerosol formulation through a dry powder inhaler. Medical uses A Cochrane review found benefit in lung functi... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Popular Topics

Arcapta drug interactions

Since I take arcapta neohaler for my emphysema I need to know if there is any drug intreraction with other drugs I am ta...